VBIV
VBI Vaccines Inc.
NASDAQHealthcareBiotechnologyUS
Company Profile
CEO
Jeffery R. Baxter FCMA
IPO Date
2010-04-26
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
VBI Vaccines Inc.
CEO
Jeffery R. Baxter FCMA
IPO Date
2010-04-26
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
| 35,000 |
| $1.30 |
| 28 Jul 2023 | Mazaltov Avi | Head Global MFG&GM-SciVac Ltd. | A-Award | Acquired | 52,500 | $1.30 |
| 28 Jul 2023 | Baxter Jeff | director, officer: CEO, President | A-Award | Acquired | 70,000 | $1.30 |
| 28 Jul 2023 | McKee Blaine H. | director | A-Award | Acquired | 35,000 | $1.30 |
| 28 Jul 2023 | Diaz-Mitoma Francisco | Chief Medical Officer | A-Award | Acquired | 52,500 | $1.30 |
| 28 Jul 2023 | Beattie Nell | director, officer: CFO, Head of Corp. Development | A-Award | Acquired | 52,500 | $1.30 |
| 28 Jul 2023 | Cordeiro Joanne | director | A-Award | Acquired | 35,000 | $1.30 |
| 28 Jul 2023 | HIMES VAUGHN B | director | A-Award | Acquired | 35,000 | $1.30 |
| 28 Jul 2023 | Anderson David Evander | Chief Scientific Officer | A-Award | Acquired | 52,500 | $1.30 |